(2S,4R)-1-((S)-2-AMINO-3,3-DIMETHYLBUTANOYL)-4-HYDROXY-N-(4-(4-METHYLTHIAZOL-5-YL)BENZYL)PYRROLIDINE-2-CARBOXAMIDE, 95%, 10g

(5-Chloro-2-(trifluoromethoxy)phenyl)boronic acid, 95.0%, 1g

L-1-Fmoc-Nipecotic acid, 97.0%, 5g

{[3-(2-Dimethylamino-5-trifluoromethyl-pyridin-3-yl)-benzyl]-methyl-amino}-acetic acid, 95.0%, 1g

Appareil à ultrasons SONOREX SUPER, avec chauffage, 0,9 l, RK 31 H 1 pièce

1-({amino[(4-chlorophenyl)amino]methylidene}amino)-N-(6-{[({amino[(4-chlorophenyl)amino]methylidene}amino)methanimidoyl]amino}hexyl)methanimidamide; bis(acetic acid), 25g

4-Phenylpyridine N-Oxide>98.0%(HPLC)(T)25g

3-(2-Butyloctyl)thiophene, 96%, 5g

(R)-TERT-BUTYL 4-ETHYL-1,2,3-OXATHIAZOLIDINE-3-CARBOXYLATE 2,2-DIOXIDE, 95.0%, 100mg

2-(Bromomethyl)-4-chloro-1-methylbenzene, 95.0%, 1g

2-Methoxythiazole-5-carbaldehyde, 95.0%, 1g

Ethyl 8-bromoisoquinoline-3-carboxylate, 97.0%, 5g

Ethyl 2-chloro-6-methylisonicotinate, 95.0%, 25g